Leads Biolabs grants Oblenio Bio an exclusive option to license LBL-051, a first-in-class CD19xBCMAxCD3 tri-specific T-cell engager antibody OAKLAND, Calif. and NANJING,…
BOSTON and INDIANAPOLIS, Nov. 7, 2024 /PRNewswire/ — Genezen, a best-in-class gene therapy contract development and manufacturing organization (CDMO), is…
ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON, Nov. 7, 2024 /PRNewswire/ —…
TAIPEI, Nov. 6, 2024 /PRNewswire/ — Appier, a software-as-a-service (SaaS) company that uses artificial intelligence (AI) to power business decision-making, is excited…